2013-25101. Manufacturer of Controlled Substances; Notice of Application; GE Healthcare  

  • Start Preamble Start Printed Page 64018

    Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 12, 2013, GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

    The company plans to manufacture a radioactive product to diagnose Parkinson's disease for distribution to its customers.

    Any other such applicant, and any person who is presently registered with DEA to manufacture such a substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

    Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 24, 2013.

    Start Signature

    Dated: October 16, 2013.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. 2013-25101 Filed 10-24-13; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
10/25/2013
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
2013-25101
Pages:
64018-64018 (1 pages)
PDF File:
2013-25101.pdf